One company, purpose-built to achieve a goal that the industry has been seeking for a long time:

Biopharmaceutical Acceleration.
" …this merger should be a big plus for small Biotech to have additional commercial options." - Customer
"The combination of INC Research and inVentiv will expand our global scale and add capabilities to grow our addressable market." - A. Macdonald, CEO
"…INCR’s deep therapeutic expertise combined with inVentiv’s FSP and CCO capabilities should provide a compelling solution…" - Wall Street Analyst
"The new organization’s combined clinical scale, therapeutic depth and expertise will allow it to partner with biopharmaceutical companies of all sizes…"- Wall Street Analyst
"…this merger has significant customer advantages as it deepens our scale, scope and therapeutic expertise." - M. Bell, Executive Chairman of the Board of Directors and President, Commercial Division

Coming January 2018

Days
Learn More

Services Highlights

inVentiv Health Clinical, a leading global supplier of drug development services, offers comprehensive capabilities and expertise in:

Learn More